공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

세계의 PCR 시장 : qPCR, dPCR, 단일 플렉스, 멀티 플렉스 시장 : 용도, 제품, 위치, 경영진 가이드와 컨설턴트 가이드(정의 예측 및 분석 포함) : COVID-19 진단의 영향을 포함한 최신 보고서(2021-2025년)

PCR Markets. Forecasts for qPCR, dPCR, Singleplex & Multiplex Markets and by Application, Product and Place. With Executive and Consultant Guides, Including Customized Forecasting and Analysis. Updated to include impact of Covid-19 Dx. 2021 to 2025

리서치사 Howe Sound Research
발행일 2021년 09월 상품 코드 1028766
페이지 정보 영문 384 Pages
가격
US $ 6,995 ₩ 8,376,000 PDF (Single User License) help
DRM(디지털 저작권 관리 시스템)이 장착된 PDF 파일로 1대의 PC에서만 이용할 수 있는 라이선스로 인쇄가 불가능합니다.
US $ 10,495 ₩ 12,567,000 PDF (Five User License) help
DRM(디지털 저작권 관리 시스템)이 장착된 PDF 파일로 5대의 PC에서만 이용할 수 있는 라이선스로 인쇄가 불가능합니다.
US $ 13,995 ₩ 16,759,000 PDF (Enterprise License) help
동일기업 내 모든 분들이 이용할 수 있는 라이선스입니다. 편집 및 인쇄는 가능하며, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.

주의 : 본 보고서는 DRM(디지털 저작권 관리 시스템)이 장착된 PDF 파일로, 라이선스에 따라 자료 이용 및 인쇄 등에 제약이 있을 수 있습니다. 자세한 내용은 라이선스 설명문( )을 참고하여 주시기 바랍니다.



세계의 PCR 시장 : qPCR, dPCR, 단일 플렉스, 멀티 플렉스 시장 : 용도, 제품, 위치, 경영진 가이드와 컨설턴트 가이드(정의 예측 및 분석 포함) : COVID-19 진단의 영향을 포함한 최신 보고서(2021-2025년) PCR Markets. Forecasts for qPCR, dPCR, Singleplex & Multiplex Markets and by Application, Product and Place. With Executive and Consultant Guides, Including Customized Forecasting and Analysis. Updated to include impact of Covid-19 Dx. 2021 to 2025
발행일 : 2021년 09월 페이지 정보 : 영문 384 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

COVID-19 진단은 PCR을 독점 기술로 하며 새로운 PCR 기반 기술 성장에 박차를 가하고 있습니다. PCR은 시장에서 그 존재를 증명했습니다. 그리고 새로운 세대의 PCR 인 디지털 PCR은 성공을 지속시킬 것으로 보여집니다. 유행 진단의 큰 수요에 힘 입어 더욱 가속화할 전망입니다. 새로운 수준의 감도는 액체 생검이나 암 검진 시장에도 영향을 미칩니다.

세계의 PCR 시장을 조사했으며, 시장 개요와 더불어 용도, 제품, 장소별 동향 및 시장 진출기업 프로필 등을 제공합니다.

목차

제1장 시장 가이드

  • 상황 분석
  • 임원 및 마케팅 직원을 위한 가이드
  • 투자 분석가 및 경영 컨설팅을 위한 가이드

제2장 서론과 시장 정의

  • PCR 기술이란 무엇인가
  • PCR 및 증후군 검사
  • 시장 정의
    • 시장 규모
    • 통화
  • 조사 방법
    • 저자
    • 소스
  • 전망 : 건강 관리, IVD 산업 및 COVID-19 유행
    • 세계의 보건 지출
    • 진단 지출
    • 진단을 위한 보험의 중요 역할

제3장 PCR-PCR 기술 가이드

  • 컨셉
    • 방법
  • 용도
    • 특정 DNA 발견
    • DNA 측정
    • 의료 및 진단 용도
  • PCR-장단점
  • 다양한 종류 PCR
    • 간단한 변경
    • 디지털 PCR
    • 등온 PCR

제4장 산업 개요

  • 역동적인 시장 플레이어
    • 학술 조사실
    • 진단 테스트 개발자
    • 게놈 계측 공급 업체
    • 의약품/시약 공급 업체
    • 독립 검사실
    • 공적 국립/지역 연구소
    • 병원 검사실
    • 실천을 위한 검사실
    • 감사 기관
    • 인증 기관

제5장 시장 동향

  • 성장 촉진 요인
    • 새로운 기준
    • 하강 곡선
    • 다중화
    • 증후군 진단
    • 유전 블리자드 증후군
  • 성장 억제 요인
    • 비용 곡선
    • 기타 사람들
    • 체계적인 장애
  • 진단 기술 개발
    • 계측 곡선
    • 진단 역할 변화
    • 병원 밖 진단
    • 혼란 임박
    • 향후 5년

제6장 PCR 최근 개발

제7장 주요 PCR 기업 프로필

  • Abacus Diagnostica
  • Abbott Diagnostics
  • Accelerate Diagnostics
  • Ador Diagnostics
  • Agilent
  • Akonni Biosystems
  • Alveo Technologies
  • Applied BioCode
  • Aus Diagnostics
  • Beckman Coulter Diagnostics
  • Becton, Dickinson and Company
  • Binx Health
  • Biocartis
  • bioM? rieux Diagnostics
  • Bioneer Corporation
  • Bio-Rad Laboratories, Inc
  • Bosch Healthcare Solutions GmbH
  • Bruker
  • Caris Molecular Diagnostics
  • Cepheid(now Danaher)
  • Credo Diagnostics Biomedical
  • Cue Health
  • Curetis NV/Curetis GmbH
  • Diagenode Diagnostics
  • Diasorin SpA
  • Enzo Life Sciences, Inc
  • Eurofins Scientific
  • Fluidigm Corp
  • Fluxergy
  • Fusion Genomics
  • Genetic Signatures
  • GenMark Dx
  • Hibergene Diagnostics
  • Hologic
  • Immunexpress
  • Inflammatix
  • Invetech
  • Janssen Diagnostics
  • Karius
  • Lexagene
  • LightDeck Diagnostics
  • Luminex Corp
  • Maxim Biomedical
  • Mbio Diagnostics
  • Meridian Bioscience
  • Mesa Biotech
  • Millipore Sigma
  • MIODx
  • Mobidiag
  • Nanomix
  • NGeneBio
  • Operon
  • Panagene
  • Perkin Elmer
  • Precipio
  • Primerdesign
  • Promega
  • Prominex
  • Qiagen Gmbh
  • Quantumdx
  • Quidel
  • Roche Molecular Diagnostics
  • Saw Diagnostics
  • Seegene
  • Siemens Healthineers
  • SkylineDx
  • Sona Nanotech
  • SpeeDx
  • T2 Biosystems
  • Thermo Fisher Scientific Inc
  • Veramarx
  • Visby Medical
  • XCR Diagnostics

제8장 세계의 PCR 시장

  • PCR-국가별 세계 시장 개요
    • 표-국가별 세계 시장
    • 차트-국가별 세계 시장
  • 용도별 세계의 시장-개요
    • 표-용도별 세계 시장
    • 차트-세계의 시장-용도별-부문 성장
    • 차트-세계의 시장-용도별 -베이스/최종 비교
    • 차트-세계의 시장-용도별-기준 연도
    • 차트-세계의 시장-용도별-마지막 연도
    • 차트-세계의 시장-용도별-연도별 점유율
  • 세계의 시장-기술별-개요
    • 표-세계의 시장-기술별
    • 차트-세계의 시장-기술별-부문 성장
    • 차트-세계의 시장-기술별 -베이스/최종 비교
    • 차트-세계의 시장-기술별-기준 연도
    • 차트-세계의 시장-기술별-마지막 연도
    • 차트-세계의 시장-기술별-연도별 점유율
  • 세계의 시장-제품별-개요
    • 표-세계의 시장-제품별
    • 차트-세계의 시장-제품별-부문 성장
    • 차트-세계의 시장-제품별 -베이스/최종 비교
    • 차트-세계의 시장-제품별-기준 연도
    • 차트-세계의 시장-제품별-마지막 연도
    • 차트-세계의 시장-제품별-연도별 점유율
  • 세계의 시장-위치별-개요
    • 표-세계의 시장-위치별
    • 차트-세계의 시장-위치별-부문 성장
    • 차트-세계의 시장-위치별 -베이스/최종 비교
    • 차트-세계의 시장-위치별-기준 연도
    • 차트-세계의 시장-위치별-마지막 연도
    • 차트-세계의 시장-위치별-연도별 점유율

제9장 세계의 PCR 시장-용도별

  • PCR 임상 멀티 플렉스
  • PCR 임상 싱글 플렉스
  • PCR 조사
  • PCR 싱글 C19
  • 기타

제10장 세계의 PCR 시장-기술별

  • qPCR
  • dPCR
  • 싱글 C19PCR
  • 기타

제11장 세계의 PCR 시장-제품별

  • PCR 장치
  • PCR 핵산 추출
  • PCR 소모품
  • PCR 서비스

제12장 세계의 PCR 시장-위치별

  • 임상 검사실
  • 포인트 오브 케어
  • 상용
  • 의약품
  • 기타

제13장 부록

NJH 21.10.12

Table of Tables

  • Table 1 Market Players by Type
  • Table 2 Five Factors Driving Growth
  • Table 3 Three Factors Limiting Growth
  • Table 4 Market Size by Country
  • Table 5 Global Market by Application
  • Table 6 Global Market by Technology
  • Table 7 Global Market by Product
  • Table 8 Global Market by Place
  • Table 9 PCR Clinical Multiplex by Country
  • Table 10 PCR Clinical Singleplex by Country
  • Table 11 PCR Research by Country
  • Table 12 PCR Single C19 by Country
  • Table 13 PCR Other by Country
  • Table 14 qPCR by Country
  • Table 15 Single C19 PCR by Country
  • Table 16 Other PCR by Country
  • Table 17 PCR Instruments by Country
  • Table 18 PCR Nucleic Acid Extraction by Country
  • Table 19 PCR Consumables by Country
  • Table 20 PCR Services by Country
  • Table 21 PCR Clinical Clinical Laboratory by Country
  • Table 22 PCR Point of Care by Country
  • Table 23 PCR Commercial by Country
  • Table 24 PCR Pharmaceutical by Country
  • Table 25 PCR Other Place by Country
  • Table 26 2021 Clinical Lab Fee Schedule

Table of Figures

  • Figure 1 Map - Global Health Care Spending Per Capita
  • Figure 2 The Lab Test Pie - Wholesale vs. Retail
  • Figure 3 The PCR Process
  • Figure 4 Creation of Sample Droplets for Digital PCR
  • Figure 5 Comparing Syndromic and Targeted Testing
  • Figure 6 Comparing The New Diagnostics and Traditional Testing
  • Figure 7 Growth rates of PCR Diagnostic Segments
  • Figure 8 Base year Global Market Share Chart
  • Figure 9 PCR Market by Application - Segments Growth
  • Figure 10 PCR Market by Application - Base vs. final
  • Figure 11 PCR Market Base year
  • Figure 12 PCR Market Final Year
  • Figure 13 Application Share by Year
  • Figure 14 PCR Market by Technology - Segments Growth
  • Figure 15 PCR Market by Technology - Base vs. final
  • Figure 16 PCR Market by Technology Base year
  • Figure 17 PCR Market by Technology Final Year
  • Figure 18 Technology Share by Year
  • Figure 19 PCR Market by Product - Segments Growth
  • Figure 20 PCR Market by Product - Base vs. final
  • Figure 21 PCR Market by Product Base year
  • Figure 22 PCR Market by Product Final Year
  • Figure 23 Product Share by Year
  • Figure 24 PCR Market by Place - Segments Growth
  • Figure 25 PCR Market by Place - Base vs. final
  • Figure 26 PCR Market by Place Base year
  • Figure 27 PCR Market by Place Final Year
  • Figure 28 Place Share by Year
  • Figure 29 PCR Clinical Multiplex Testing Growth
  • Figure 30 PCR Clinical Singleplex Testing Growth
  • Figure 31 PCR Research Growth
  • Figure 32 PCR Single C19 Growth
  • Figure 33 PCR Other Growth
  • Figure 34 qPCR Growth
  • Figure 35 dPCR Growth
  • Figure 36 Single C19 PCR Growth
  • Figure 37 Other PCR Growth
  • Figure 38 PCR Instruments Growth
  • Figure 39 PCR Nucleic Acid Extraction Growth
  • Figure 40 PCR Consumables Growth
  • Figure 41 PCR Services Growth
  • Figure 42 PCR Clinical Clinical Laboratory Growth
  • Figure 43 PCR Point of Care Growth
  • Figure 44 PCR Commercial Growth
  • Figure 45 PCR Pharmaceutical Growth
  • Figure 46 PCR Other Place Growth

OVERVIEW:

COVID-19 Diagnostics is driving PCR into a dominant technology role and spurring the growth of new PCR based technologies. Will thermal cycling become obsolete?

Are singleplex tests going to be obsolete? Will routine respiratory screening become a reality? Will diagnostics move into the Physician's Office or even the Home? Will digital PCR become the new lab standard?

The report forecasts the market size out to 2025 with the only analysis available that breaks out Singleplex and Multiplex testing markets. PCR has proved itself in the market. And the new generation of PCR, digital PCR promises to keep that success going. Driven even faster by the huge demand for pandemic diagnostics. New levels of sensitivity have implications for Liquid Biopsy and Cancer Screening markets. Lowering costs, improving outcomes and even helping in the battle against Anti Microbial Resistance. Learn about this market including the issues and outlooks. The two key trends of Point of Care Testing and Molecular Diagnostics are merging with spectacular success.

All report data is available in Excel format on request.

Make investment decisions and valuations with confidence using the latest data.

ABOUT THE LEAD AUTHOR:

Mr. Greg Powell, B.SC., M.B.A is the President of Howe Sound Research. He is an experienced business and clinical professional. He is co-author of the paper "The Radioimmunoassay of Angiotensinogen by Antibody Trapping." He has worked in laboratory testing and management for over 20 years. Mr. Powell's education includes:

  • B.Sc. (Chemistry) University of BC
  • M.B.A. (Finance and Policy) University of BC
  • Market Research Seminar - Burke Institute
  • Finance for Senior Executives - Harvard Business School

Table of Contents

1 Market Guides

  • 1.1 Situation Analysis
  • 1.2 Guide for Executives and Marketing Staff
  • 1.3 Guide for Investment Analysts and Management Consultants

2 Introduction and Market Definition

  • 2.1 What are PCR Technologies?
  • 2.2 PCR and Syndromic Testing
  • 2.3 Market Definition
    • 2.3.1 Market Size
    • 2.3.2 Currency
    • 2.3.3 Years
  • 2.4 Methodology
    • 2.4.1 Authors
    • 2.4.2 Sources
  • 2.5 Perspective: Healthcare, the IVD Industry, and the COVID-19 Pandemic
    • 2.5.1 Global Healthcare Spending
    • 2.5.2 Spending on Diagnostics
    • 2.5.3 Important Role of Insurance for Diagnostics

3 PCR - Guide to PCR Technologies

  • 3.1 Concepts
    • 3.1.1 Method
  • 3.2 Applications
    • 3.2.1 Finding Specific DNA
    • 3.2.2 Measuring DNA
    • 3.2.3 Medical and Diagnostic Applications
      • 3.2.3.1 Carrier, prenatal and tissue typing
      • 3.2.3.2 Cancer Diagnosis and Management
      • 3.2.3.3 Infectious Disease - New Levels of Accuracy and Sensitivity
      • 3.2.3.4 Forensic Applications
      • 3.2.3.5 Science and Research
  • 3.3 PCR - Advantages and Disadvantages
  • 3.4 Different Types of PCR
    • 3.4.1 Simple Changes
      • 3.4.1.1 Multiplex-PCR
      • 3.4.1.2 VNTR PCR
      • 3.4.1.3 Asymmetric PCR
      • 3.4.1.4 Long PCR
      • 3.4.1.5 Nested PCR
      • 3.4.1.6 Quantitative PCR
      • 3.4.1.7 Hot-start PCR
      • 3.4.1.8 Touchdown PCR
      • 3.4.1.9 Assembly PCR
      • 3.4.1.10 Colony PCR
      • 3.4.1.11 Suicide PCR
      • 3.4.1.12 Cold PCR
    • 3.4.2 Digital PCR
      • 3.4.2.1 Droplet Digital PCR
      • 3.4.2.2 Comparison between dPCR and Real-Time PCR (qPCR)
      • 3.4.2.3 Digital PCR in Use
      • 3.4.2.4 Digital PCR Commercial History
    • 3.4.3 Isothermal PCR

4 Industry Overview

  • 4.1 Players in a Dynamic Market
    • 4.1.1 Academic Research Lab
    • 4.1.2 Diagnostic Test Developer
    • 4.1.3 Genomic Instrumentation Supplier
      • 4.1.3.1 Cell Separation and Viewing Instrumentation Supplier
    • 4.1.4 Pharmaceutical/Reagent Supplier
    • 4.1.5 Independent Testing Lab
    • 4.1.6 Public National/regional lab
    • 4.1.7 Hospital lab
    • 4.1.8 Physician Lab
    • 4.1.9 Audit Body
    • 4.1.10 Certification Body

5 Market Trends

  • 5.1 Factors Driving Growth
    • 5.1.1 A New Standard
    • 5.1.2 Down the Curve We Go
    • 5.1.3 Multiplexing
    • 5.1.4 Syndromic Diagnostics Looks Unstoppable
    • 5.1.5 The Genetic Blizzard
  • 5.2 Factors Limiting Growth
    • 5.2.1 The Cost Curve
    • 5.2.2 The Other Guys
    • 5.2.3 Systemic Roadblocks
  • 5.3 Diagnostic Technology Development
    • 5.3.1 The Instrumentation Curve
    • 5.3.2 Shifting Role of Diagnostics
    • 5.3.3 Diagnostics Moves Out of the Hospital
    • 5.3.4 Disruption Looms
    • 5.3.5 The Next Five Years

6 PCR Recent Developments

  • 6.1 Recent Developments - Importance and How to Use This Section
    • 6.1.1 Importance of These Developments
    • 6.1.2 How to Use This Section
  • 6.2 Chelex-Based Protocol to Reduce Cost, Time for PCR Testing
  • 6.3 Finnish Firms to Form Point-of-Care Testing Firm
  • 6.4 Visby Medical Scales Up Handheld PCR Test for STIs
  • 6.5 DnaNudge Raises $60M
  • 6.6 Roche Reports Diagnostics Revenue Up 51 Percent
  • 6.7 BforCure Preparing Multiple ID Panels for PoC qPCR Platform
  • 6.8 Enzo Biochem, CLX Health Partner for C19 Testing for Travel
  • 6.9 Bio Molecular Systems Gets Approval for Portable PCR Cycler
  • 6.10 Roche Acquires GenMark
  • 6.11 Handheld qPCR Devices Close to Commercialization
  • 6.12 Nuclein Closes $14M in Funding
  • 6.13 WuXi Diagnostics Closes $150M Series B Financing Round
  • 6.14 Visby Medical to develop rapid Flu-COVID PCR test
  • 6.15 Thermo Fisher to acquire Mesa Biotech
  • 6.16 Scope Fluidics Secures €6.2M Supporting Rapid MDx
  • 6.17 SARS- Testing Demand to Continue 'Through 2022, and Beyond'
  • 6.18 Malaria Assays Use CRISPR for Point-of-Care Multispecies Detection
  • 6.19 Fluidigm Saliva Test for SARS-CoV-2 Uses Extraction-free RT-PCR
  • 6.20 Visby Medical Gonorrhea Test Wins $19M AMR Diagnostic Competition
  • 6.21 HelixBind Receives $3M NIH Grant to Expand Infection Dx Platform
  • 6.22 Nucleix Targeting US Market With Bladder, Lung Cancer Assays
  • 6.23 DxTerity Gets CE Mark for At-Home Sample Collection Device
  • 6.24 Fetal Cell-Based NIPT by dDigital PCR Demonstrated
  • 6.25 ChromaCode Raises $28M for new High Def PCR Technology
  • 6.26 ddPCR Used for Fast and Low-Cost NIPT Screening
  • 6.27 Study Validates ChromaCode HDPCR™ Testing for Tick-Borne Pathogens
  • 6.28 Bio-Rad's ddPCR MSI RUO Assay is available
  • 6.29 ctDNA Monitoring Is Important for BRAF-Mutant Melanoma
  • 6.30 Sysmex Inostics Liquid Biopsy Demonstrates Two-fold Higher Detection
  • 6.31 QIAGEN Plans for Next-Generation Digital PCR Systems
  • 6.32 Bioneer HIV-1 Dx Kit Gets Korea FDA Approval
  • 6.33 New PCR Technology: Transfer-PCR (tPCR) Applications
  • 6.34 NimaGen Licenses PCR Tech from Salisbury NHS Foundation Trust
  • 6.35 Natera Applies Massively Multiplexed PCR to Kidney Transplants
  • 6.36 Paragon Genomics, MGI Tech Form Distribution Alliance

7 Profiles of Key PCR Companies

  • 7.1 Abacus Diagnostica
  • 7.2 Abbott Diagnostics
  • 7.3 Accelerate Diagnostics
  • 7.4 Ador Diagnostics
  • 7.5 Agilent
  • 7.6 Akonni Biosystems
  • 7.7 Alveo Technologies
  • 7.8 Applied BioCode
  • 7.9 Aus Diagnostics
  • 7.10 Beckman Coulter Diagnostics
  • 7.11 Becton, Dickinson and Company
  • 7.12 Binx Health
  • 7.13 Biocartis
  • 7.14 bioMérieux Diagnostics
  • 7.15 Bioneer Corporation
  • 7.16 Bio-Rad Laboratories, Inc
  • 7.17 Bosch Healthcare Solutions GmbH
  • 7.18 Bruker
  • 7.19 Caris Molecular Diagnostics
  • 7.20 Cepheid (now Danaher)
  • 7.21 Credo Diagnostics Biomedical
  • 7.22 Cue Health
  • 7.23 Curetis N.V. / Curetis GmbH
  • 7.24 Diagenode Diagnostics
  • 7.25 Diasorin S.p.A
  • 7.26 Enzo Life Sciences, Inc
  • 7.27 Eurofins Scientific
  • 7.28 Fluidigm Corp
  • 7.29 Fluxergy
  • 7.30 Fusion Genomics
  • 7.31 Genetic Signatures
  • 7.32 GenMark Dx
  • 7.33 Hibergene Diagnostics
  • 7.34 Hologic
  • 7.35 Immunexpress
  • 7.36 Inflammatix
  • 7.37 Invetech
  • 7.38 Janssen Diagnostics
  • 7.39 Karius
  • 7.40 Lexagene
  • 7.41 LightDeck Diagnostics
  • 7.42 Luminex Corp
  • 7.43 Maxim Biomedical
  • 7.44 Mbio Diagnostics
  • 7.45 Meridian Bioscience
  • 7.46 Mesa Biotech
  • 7.47 Millipore Sigma
  • 7.48 MIODx
  • 7.49 Mobidiag
  • 7.50 Nanomix
  • 7.51 NGeneBio
  • 7.52 Operon
  • 7.53 Panagene
  • 7.54 Perkin Elmer
  • 7.55 Precipio
  • 7.56 Primerdesign
  • 7.57 Promega
  • 7.58 Prominex
  • 7.59 Qiagen Gmbh
  • 7.60 Quantumdx
  • 7.61 Quidel
  • 7.62 Roche Molecular Diagnostics
  • 7.63 Saw Diagnostics
  • 7.64 Seegene
  • 7.65 Siemens Healthineers
  • 7.66 SkylineDx
  • 7.67 Sona Nanotech
  • 7.68 SpeeDx
  • 7.69 T2 Biosystems
  • 7.70 Thermo Fisher Scientific Inc
  • 7.71 Veramarx
  • 7.72 Visby Medical
  • 7.73 XCR Diagnostics

8 The Global PCR Markets

  • 8.1 PCR - Global Market Overview by Country
    • 8.1.1 Table - Global Market by Country
    • 8.1.2 Chart - Global Market by Country
  • 8.2 Global Market by Application - Overview
    • 8.2.1 Table - Global Market by Application
    • 8.2.2 Chart - Global Market by Application - Segments Growth
    • 8.2.3 Chart - Global Market by Application - Base/Final Comparison
    • 8.2.4 Chart - Global Market by Application - Base Year
    • 8.2.5 Chart - Global Market by Application - Final Year
    • 8.2.6 Chart - Global Market by Application - Share by Year
  • 8.3 Global Market by Technology - Overview
    • 8.3.1 Table - Global Market by Technology
    • 8.3.2 Chart - Global Market by Technology - Segments Growth
    • 8.3.3 Chart - Global Market by Technology - Base/Final Comparison
    • 8.3.4 Chart - Global Market by Technology - Base Year
    • 8.3.5 Chart - Global Market by Technology - Final Year
    • 8.3.6 Chart - Global Market by Technology - Share by Year
  • 8.4 Global Market by Product - Overview
    • 8.4.1 Table - Global Market by Product
    • 8.4.2 Chart - Global Market by Product - Segments Growth
    • 8.4.3 Chart - Global Market by Product - Base/Final Comparison
    • 8.4.4 Chart - Global Market by Product - Base Year
    • 8.4.5 Chart - Global Market by Product - Final Year
    • 8.4.6 Chart - Global Market by Product - Share by Year
  • 8.5 Global Market by Place - Overview
    • 8.5.1 Table - Global Market by Place
    • 8.5.2 Chart - Global Market by Place - Segments Growth
    • 8.5.3 Chart - Global Market by Place - Base/Final Comparison
    • 8.5.4 Chart - Global Market by Place - Base Year
    • 8.5.5 Chart - Global Market by Place - Final Year
    • 8.5.6 Chart - Global Market by Place - Share by Year

9 Global PCR Markets - By Application

  • 9.1 PCR Clinical Multiplex
    • 9.1.1 Table PCR Clinical Multiplex Testing - by Country
    • 9.1.2 Chart - PCR Clinical Multiplex Testing Growth
  • 9.2 PCR Clinical Singleplex
    • 9.2.1 Table PCR Clinical Singleplex Testing - by Country
    • 9.2.2 Chart - PCR Clinical Singleplex Testing Growth
  • 9.3 PCR Research
    • 9.3.1 Table PCR Research - by Country
    • 9.3.2 Chart - PCR Research Growth
  • 9.4 PCR Single C19
    • 9.4.1 Table PCR Single C19 - by Country
    • 9.4.2 Chart - PCR Single C19 Growth
  • 9.5 PCR Other
    • 9.5.1 Table PCR Other - by Country
    • 9.5.2 Chart - PCR Other Growth

10 Global PCR Markets - By Technology

  • 10.1 qPCR
    • 10.1.1 Table qPCR - by Country
    • 10.1.2 Chart - qPCR Growth
  • 10.2 dPCR
    • 10.2.1 Table dPCR - by Country
    • 10.2.2 Chart - dPCR Growth
  • 10.3 Single C19 PCR
    • 10.3.1 Table Single C19 PCR - by Country
    • 10.3.2 Chart - Single C19 PCR Growth
  • 10.4 Other PCR
    • 10.4.1 Table Other PCR - by Country
    • 10.4.2 Chart - Other PCR Growth

11 Global PCR Markets - By Product

  • 11.1 PCR Instruments
    • 11.1.1 Table PCR Instruments - by Country
    • 11.1.2 Chart - PCR Instruments Growth
  • 11.2 PCR Nucleic Acid Extraction
    • 11.2.1 Table PCR Nucleic Acid Extraction - by Country
    • 11.2.2 Chart - PCR Nucleic Acid Extraction Growth
  • 11.3 PCR Consumables
    • 11.3.1 Table PCR Consumables - by Country
    • 11.3.2 Chart - PCR Consumables Growth
  • 11.4 PCR Services
    • 11.4.1 Table Services - by Country
    • 11.4.2 Chart - PCR Services Growth

12 Global PCR Markets - By Place

  • 12.1 PCR Clinical Laboratory
    • 12.1.1 Table PCR Clinical Clinical Laboratory - by Country
    • 12.1.2 Chart - PCR Clinical Clinical Laboratory Growth
  • 12.2 PCR Point of Care
    • 12.2.1 Table PCR Point of Care - by Country
    • 12.2.2 Chart - PCR Point of Care Growth
  • 12.3 PCR Commercial
    • 12.3.1 Table PCR Commercial - by Country
    • 12.3.2 Chart - PCR Commercial Growth
  • 12.4 PCR Pharmaceutical
    • 12.4.1 Table PCR Pharmaceutical - by Country
    • 12.4.2 Chart - PCR Pharmaceutical Growth
  • 12.5 PCR Other Place
    • 12.5.1 Table PCR Other Place - by Country
    • 12.5.2 Chart - PCR Other Place Growth

13 Appendices

  • 13.1 I. United States Medicare System: 2021 Clinical Laboratory Fees Schedule
Back to Top
전화 문의
F A Q